Nonalcoholic fatty liver disease: molecular pathways and therapeutic strategies

Along with rising numbers of patients with metabolic syndrome, the prevalence of nonalcoholic fatty liver disease (NAFLD) has increased in proportion with the obesity epidemic. While there are no established treatments for NAFLD, current research is targeting new molecular mechanisms that underlie N...

Descripción completa

Detalles Bibliográficos
Autores principales: Huang, Yue Ye, Gusdon, Aaron M, Qu, Shen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827997/
https://www.ncbi.nlm.nih.gov/pubmed/24209497
http://dx.doi.org/10.1186/1476-511X-12-171

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827997/
https://www.ncbi.nlm.nih.gov/pubmed/24209497
http://dx.doi.org/10.1186/1476-511X-12-171

Ejemplares similares